Laura K. Aguilar - Jul 26, 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Medical Officer
Signature: /s/ Laura K. Aguilar
Stock symbol: CADL
Transactions as of: Jul 26, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/26/2021, 09:22 PM
Next filing: Aug 2, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CADL	Common Stock						875K	Jul 26, 2021	Direct
holding	CADL	Common Stock						2.01M	Jul 26, 2021	By Laura K. Aguilar 2020 Irrevocable Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	17.9K	$1.46	Direct	F2
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	76.7K	$1.46	Direct	F3
holding	CADL	Series B Preferred Stock							Jul 26, 2021	Common Stock	56.1K		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Laura K. Aguilar 2020 Irrevocable Trust . The Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein, if any.
F2	25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in three substantially equal annual installments thereafter.
F3	This option shall vest and become exercisable in four substantially equal annual installments, with the first installment vesting on November 13, 2018.
F4	The Series B Preferred Stock has no expiration date.
F5	Includes 32,399 shares held jointly with spouse.